Merus logo.jpg
Merus gibt Finanzergebnisse für das vierte Quartal und Gesamtjahresergebnisse für das Jahr 2023 bekannt und legt ein Update zur Geschäftsentwicklung vor
March 01, 2024 16:15 ET | Merus N.V.
– Petosemtamab als 1L bei HNSCC in Kombination mit Pembrolizumab – erste vorläufige klinische Daten für das 2. Quartal 2024 geplant; Vorbereitung einer möglichen Phase-III-Studie – Start der...
Picture2.jpg
StoneX Group Inc. Announces Closing of $550 Million of Senior Secured Notes due 2031
March 01, 2024 16:15 ET | StoneX Group Inc.
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- StoneX Group Inc. (the “Company”; NASDAQ: SNEX), today announced the closing of its previously-announced offering of $550 million in aggregate principal...
Logo.jpg
Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
March 01, 2024 16:05 ET | Magic Empire Global Limited
Hong Kong, March 01, 2024 (GLOBE NEWSWIRE) -- Magic Empire Global Limited (NASDAQ: MEGL) (“MEGL”, or the “Company”) announced that, on February 28, 2024, the Company received a letter from the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
March 01, 2024 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation...
Disruptors being prepared for deployment at Bear and Chief
Cipher Mining Announces February 2024 Operational Update
March 01, 2024 16:05 ET | Cipher Mining Inc.
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for February 2024. Key...
X4-logo.png
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024 16:05 ET | X4 Pharmaceuticals
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
Nasdaq.jpg.prdesk.globenewswire.jpg
Nasdaq Chief Financial Officer Sarah Youngwood to Present at the Morgan Stanley Technology, Media & Telecom Conference
March 01, 2024 16:05 ET | Nasdaq, Inc.
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq’s Investor Relations website:...
Hi Resolution Silvercrest Logo_Color.jpg
Silvercrest Asset Management (SAMG) to Announce Fourth Quarter and Year-End 2023 Results and Host Investor Conference Call
March 01, 2024 16:01 ET | Silvercrest Asset Management Group Inc.
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host a teleconference at 8:30 am Eastern Time on March 8, 2024, to discuss...
Lyra-Logo-RGB-small.jpg
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024 16:01 ET | Lyra Therapeutics
WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting,...
Absci-NameLogo.png
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
March 01, 2024 16:01 ET | Absci Corporation
VANCOUVER, Wash., March 01, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, today announced the closing of its underwritten...